DK2239253T3 - Hidtil ukendt phenylpyrrolderivat - Google Patents
Hidtil ukendt phenylpyrrolderivatInfo
- Publication number
- DK2239253T3 DK2239253T3 DK09708422.2T DK09708422T DK2239253T3 DK 2239253 T3 DK2239253 T3 DK 2239253T3 DK 09708422 T DK09708422 T DK 09708422T DK 2239253 T3 DK2239253 T3 DK 2239253T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylpyr
- derivative
- roller
- hitherto unknown
- hitherto
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008026519 | 2008-02-06 | ||
JP2008314479 | 2008-12-10 | ||
PCT/JP2009/051834 WO2009099080A1 (ja) | 2008-02-06 | 2009-02-04 | 新規フェニルピロール誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2239253T3 true DK2239253T3 (da) | 2013-09-23 |
Family
ID=40952154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09708422.2T DK2239253T3 (da) | 2008-02-06 | 2009-02-04 | Hidtil ukendt phenylpyrrolderivat |
Country Status (21)
Country | Link |
---|---|
US (2) | US8017610B2 (da) |
EP (1) | EP2239253B1 (da) |
JP (2) | JP4503101B2 (da) |
KR (1) | KR20100118979A (da) |
CN (1) | CN102015637B (da) |
AU (1) | AU2009211718B2 (da) |
BR (1) | BRPI0908124A2 (da) |
CA (1) | CA2715143C (da) |
CO (1) | CO6331462A2 (da) |
DK (1) | DK2239253T3 (da) |
ES (1) | ES2425190T3 (da) |
HK (1) | HK1148740A1 (da) |
IL (1) | IL207372A0 (da) |
MX (1) | MX2010008637A (da) |
MY (1) | MY150269A (da) |
NZ (1) | NZ587126A (da) |
PL (1) | PL2239253T3 (da) |
PT (1) | PT2239253E (da) |
RU (1) | RU2470917C2 (da) |
TW (1) | TWI432429B (da) |
WO (1) | WO2009099080A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010082601A1 (ja) * | 2009-01-16 | 2010-07-22 | 第一三共株式会社 | 新規2,5-二置換ピロール誘導体 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011122458A1 (ja) * | 2010-03-29 | 2011-10-06 | 第一三共株式会社 | 含窒素芳香環化合物 |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
EP2703400A4 (en) * | 2011-04-27 | 2014-10-08 | Daiichi Sankyo Co Ltd | PHENYLPYRROLDERIVAT CRYSTAL |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2018019758A1 (en) | 2016-07-26 | 2018-02-01 | Basf Se | Herbicidal pyridine compounds |
EP3275877A1 (en) | 2016-07-28 | 2018-01-31 | Basf Se | Herbicidal pyridine compounds |
WO2018019770A1 (en) | 2016-07-28 | 2018-02-01 | Basf Se | Herbicidal pyridine compounds |
TWI826531B (zh) | 2018-09-21 | 2023-12-21 | 南韓商愛思開生物製藥股份有限公司 | 具有㗁二唑之化合物及包含該化合物之醫藥組合物 |
CN112142716B (zh) * | 2020-10-29 | 2021-08-31 | 山东新时代药业有限公司 | 一种5元杂芳基取代的吡嗪衍生物及其应用 |
CN112707898A (zh) * | 2020-12-21 | 2021-04-27 | 徐新杰 | 一种杂芳基取代的吡嗪衍生物及其应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01009814A (es) | 1999-03-29 | 2002-04-24 | Hoffmann La Roche | Activadores de la glucoquinasa. |
US6320050B1 (en) | 1999-03-29 | 2001-11-20 | Hoffmann-La Roche Inc. | Heteroaromatic glucokinase activators |
DE60328671D1 (de) | 2002-03-26 | 2009-09-17 | Banyu Pharma Co Ltd | Neue aminobenzamidderivate |
CN101712657A (zh) | 2003-02-26 | 2010-05-26 | 万有制药株式会社 | 杂芳基氨基甲酰基苯衍生物 |
GB0325402D0 (en) | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
US7728025B2 (en) * | 2003-12-29 | 2010-06-01 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted benzimidazole derivative |
SI1723128T1 (sl) | 2004-01-06 | 2013-04-30 | Transtech Pharma, Inc. | Heteroaril uree in njihova uporaba kot aktivatorji glukokinaze |
WO2005080359A1 (en) | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Benzamide derivatives and their use as glucokinae activating agents |
GB0403593D0 (en) * | 2004-02-18 | 2004-03-24 | Astrazeneca Ab | Compounds |
CA2560286A1 (en) | 2004-03-23 | 2005-09-29 | Banyu Pharmaceutical Co., Ltd. | Substituted quinazoline or pyridopyrimidine derivative |
KR100870346B1 (ko) * | 2004-05-10 | 2008-11-25 | 에프. 호프만-라 로슈 아게 | 비만 치료용 피롤 또는 이미다졸 아마이드 |
US20090264650A1 (en) * | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
US8957070B2 (en) | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
WO2006132436A1 (ja) * | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | 複素環化合物 |
CA2613303C (en) | 2005-07-11 | 2012-06-19 | Mitsubishi Tanabe Pharma Corporation | An oxime derivative for use as a glucokinase activator |
WO2007031739A1 (en) | 2005-09-16 | 2007-03-22 | Astrazeneca Ab | Heterobicyclic compounds as glucokinase activators |
JP4990783B2 (ja) | 2005-09-30 | 2012-08-01 | Msd株式会社 | 2−ヘテロアリール置換インドール誘導体 |
EP1951706A1 (en) | 2005-11-01 | 2008-08-06 | Janssen Pharmaceutica N.V. | Dihydroisoindolones as allosteric modulators of glucokinase |
CN101321747A (zh) | 2005-11-01 | 2008-12-10 | 詹森药业有限公司 | 作为葡萄糖激酶变构调节剂的取代的环烷基吡咯酮类 |
JP2009515997A (ja) | 2005-11-18 | 2009-04-16 | タケダ サン ディエゴ インコーポレイテッド | グルコキナーゼ活性剤 |
US8022223B2 (en) | 2006-03-24 | 2011-09-20 | Array Biopharma, Inc. | 2-aminopyridine analogs as glucokinase activators |
US8318746B2 (en) | 2007-04-27 | 2012-11-27 | Takeda Pharmaceutical Company Limited | Nitrogen-containing five-membered heterocyclic compound |
-
2009
- 2009-02-04 PL PL09708422T patent/PL2239253T3/pl unknown
- 2009-02-04 CN CN200980112177.8A patent/CN102015637B/zh not_active Expired - Fee Related
- 2009-02-04 JP JP2009552480A patent/JP4503101B2/ja not_active Expired - Fee Related
- 2009-02-04 RU RU2010136953/04A patent/RU2470917C2/ru not_active IP Right Cessation
- 2009-02-04 MY MYPI2010003478A patent/MY150269A/en unknown
- 2009-02-04 NZ NZ587126A patent/NZ587126A/en not_active IP Right Cessation
- 2009-02-04 KR KR1020107017370A patent/KR20100118979A/ko active IP Right Grant
- 2009-02-04 PT PT97084222T patent/PT2239253E/pt unknown
- 2009-02-04 AU AU2009211718A patent/AU2009211718B2/en not_active Ceased
- 2009-02-04 CA CA2715143A patent/CA2715143C/en not_active Expired - Fee Related
- 2009-02-04 MX MX2010008637A patent/MX2010008637A/es active IP Right Grant
- 2009-02-04 EP EP09708422.2A patent/EP2239253B1/en not_active Not-in-force
- 2009-02-04 BR BRPI0908124-0A patent/BRPI0908124A2/pt not_active IP Right Cessation
- 2009-02-04 DK DK09708422.2T patent/DK2239253T3/da active
- 2009-02-04 WO PCT/JP2009/051834 patent/WO2009099080A1/ja active Application Filing
- 2009-02-04 ES ES09708422T patent/ES2425190T3/es active Active
- 2009-02-05 TW TW098103602A patent/TWI432429B/zh not_active IP Right Cessation
-
2010
- 2010-03-11 JP JP2010053934A patent/JP5074545B2/ja not_active Expired - Fee Related
- 2010-07-26 US US12/843,348 patent/US8017610B2/en not_active Expired - Fee Related
- 2010-08-03 IL IL207372A patent/IL207372A0/en unknown
- 2010-09-03 CO CO10109309A patent/CO6331462A2/es active IP Right Grant
-
2011
- 2011-03-22 HK HK11102874.4A patent/HK1148740A1/xx not_active IP Right Cessation
- 2011-08-05 US US13/198,819 patent/US8415359B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2009211718A1 (en) | 2009-08-13 |
TW200938539A (en) | 2009-09-16 |
HK1148740A1 (en) | 2011-09-16 |
MY150269A (en) | 2013-12-31 |
ES2425190T3 (es) | 2013-10-14 |
CN102015637A (zh) | 2011-04-13 |
CO6331462A2 (es) | 2011-10-20 |
IL207372A0 (en) | 2010-12-30 |
PT2239253E (pt) | 2013-09-17 |
JPWO2009099080A1 (ja) | 2011-05-26 |
CA2715143A1 (en) | 2009-08-13 |
JP5074545B2 (ja) | 2012-11-14 |
WO2009099080A1 (ja) | 2009-08-13 |
US8415359B2 (en) | 2013-04-09 |
EP2239253A4 (en) | 2011-02-23 |
RU2010136953A (ru) | 2012-03-20 |
JP2010163449A (ja) | 2010-07-29 |
US20120022075A1 (en) | 2012-01-26 |
US20110003787A1 (en) | 2011-01-06 |
EP2239253A1 (en) | 2010-10-13 |
MX2010008637A (es) | 2010-08-30 |
CN102015637B (zh) | 2014-05-21 |
NZ587126A (en) | 2011-12-22 |
RU2470917C2 (ru) | 2012-12-27 |
BRPI0908124A2 (pt) | 2015-08-04 |
US8017610B2 (en) | 2011-09-13 |
TWI432429B (zh) | 2014-04-01 |
CA2715143C (en) | 2013-04-02 |
KR20100118979A (ko) | 2010-11-08 |
JP4503101B2 (ja) | 2010-07-14 |
AU2009211718B2 (en) | 2011-08-11 |
PL2239253T3 (pl) | 2013-11-29 |
EP2239253B1 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2239253T3 (da) | Hidtil ukendt phenylpyrrolderivat | |
DK2308877T3 (da) | Imidazopyridin-2-on-derivater | |
BRPI0907376A2 (pt) | Fotobiorretador | |
DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
ATE545635T1 (de) | Substituierte n-oxidpyrazinderivate | |
BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
BRPI0911625A2 (pt) | Métodos | |
ATE534634T1 (de) | 2-phenyl-4-cyclopropyl-pyrimidinderivate | |
BRPI0907522A2 (pt) | biarlamidas | |
BRPI0922652A2 (pt) | Derivados de quinazolinamida | |
DK2252403T3 (da) | Valsemølle | |
BRPI0914098A2 (pt) | biosensor | |
AT507449A3 (de) | Dämmstoffbefestiger | |
BRPI0909425A2 (pt) | derivado de hidroxiquinoxalinacarboxamida | |
ATE553672T1 (de) | Rollenausziehführung | |
TH105092B (th) | อนุพันธ์เบนโซควินาโซลีน | |
FI20085096A0 (fi) | Telojen kunnostus | |
ES1068672Y (es) | Estructura de rodillo abujardador | |
FI8224U1 (fi) | Kuivain | |
BRPI0907857A2 (pt) | derivado de bicicloamina | |
ES1068837Y (es) | Mosquitera corredera | |
UA18259S (uk) | Профіль |